UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: DepoMedrolcumLido-4010-SE-AJ-MPD-BBDL

Depo-Medrol cum lidocain 40 mg/ml+10 mg/ml Injektionsvätska, suspension

MPID: SE-100001390-00009493
EURDID: 1879

Full name: Depo-Medrol cum lidocain 40 mg/ml+10 mg/ml Injektionsvätska, suspension

- Invented Name Part: Depo-Medrol cum lidocain

- Strength part: 40 mg/ml + 10 mg/ml

- Pharmaceutical dose form part: Injektionsvätska, suspension

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Suspension for injection

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000096038 methylprednisolone

Marketing Authorisation 1 of 1

Authorisation number: 9493

Region: Kingdom of Sweden

Marketing authorisation holder: Pfizer AB

Identifier:

  • LOC-100057908

Status: Valid (1980-03-28)

Package 1 of 2

PCID:

Description:
Injektionsflaska, 10 x 1 ml

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 10 vial

Package: 1 Box (Cardboard)

Containing:

Package: 10 Vial (Glass)

Containing: 1 millilitre(s)

Manufactured Item

Dose form: Suspension for injection

Unit of presentation: Vial

Ingredient

Role: Active

Substance: lidocaine hydrochloride

Concentration strength: 10 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine 8.65 milligram(s) / 1 millilitre(s)

Ingredient

Role: Active

Substance: Methylprednisolone acetate

Concentration strength: 40 milligram(s) / 1 millilitre(s)

Reference strength:
methylprednisolone ph. eur. 35.96 milligram(s) / 1 millilitre(s)

Package 2 of 2

PCID:

Description:
Injektionsflaska, 25 x 1 ml

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 25 vial

Package: 1 Box (Cardboard)

Containing:

Package: 25 Vial (Glass)

Containing: 1 millilitre(s)

Manufactured Item

Dose form: Suspension for injection

Unit of presentation: Vial

Ingredient

Role: Active

Substance: lidocaine hydrochloride

Concentration strength: 10 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine 8.65 milligram(s) / 1 millilitre(s)

Ingredient

Role: Active

Substance: Methylprednisolone acetate

Concentration strength: 40 milligram(s) / 1 millilitre(s)

Reference strength:
methylprednisolone ph. eur. 35.96 milligram(s) / 1 millilitre(s)

Administrable Product (1 of 1)

Dose form: Suspension for injection

Unit of presentation:

Route of administration:

  • Periarticular use

Ingredients:

Ingredient

Role: Active

Substance: lidocaine hydrochloride

Concentration strength: 10 milligram(s) / 1 millilitre(s)

Reference strength:
lidocaine 8.65 milligram(s) / 1 millilitre(s)

Ingredient

Role: Active

Substance: Methylprednisolone acetate

Concentration strength: 40 milligram(s) / 1 millilitre(s)

Reference strength:
methylprednisolone ph. eur. 35.96 milligram(s) / 1 millilitre(s)